TetraLogic Pharmaceuticals Corporation
TLOGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$979
P/E Ratio—
52W High$0.001
52W Low$0.00004
TetraLogic Pharmaceuticals Corporation (TLOG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TLOG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2015-12 | 2014-12 | 2013-12 | 2012-12 | 2011-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.02B | $0.01B | $0.01B | $0.02B |
| G&A Expenses | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.04B | $0.03B | $0.02B | $0.02B | $0.02B |
| Operating Income | ($0.04B) | ($0.03B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.05B) | ($0.04B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.06B) | ($0.04B) | ($0.02B) | ($0.02B) | ($0.02B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.37 | $-1.76 | $-9.90 | $-16.78 | $-14.80 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.04B) | ($0.03B) | ($0.02B) | ($0.02B) | ($0.02B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more TetraLogic Pharmaceuticals Corporation data
About TetraLogic Pharmaceuticals Corporation (TLOG) Income Statement
TetraLogic Pharmaceuticals Corporation (TLOG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2015, TLOG reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.06B) — a net profit margin of —.
Frequently asked questions
TLOG · 4 questionsTetraLogic Pharmaceuticals Corporation (TLOG) reported revenue of $0.00B for 2015, down —% year-over-year.
TLOG revenueTLOG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09